132 related articles for article (PubMed ID: 3002013)
1. Light and electron microscopic localization of the N-terminal fragment of human pro-opiomelanocortin in the human pituitary gland and in neoplasms.
Osamura RY; Watanabe K; Seidah NG; Chan JS; Chrétien M
Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):281-7. PubMed ID: 3002013
[TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopic localization of ACTH and pro-opiomelanocortin-derived peptides in human developmental and neoplastic cells.
Osamura RY; Tsutsumi Y; Watanabe K
J Histochem Cytochem; 1984 Aug; 32(8):885-93. PubMed ID: 6086743
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin (ACTH) and the N-terminal fragment of pro-opiomelanocortin are located in the same granules in cells of rat pituitary gland.
Cantin M; Ballak M; Lu CL; Seidah NG; Chrétien M
J Histochem Cytochem; 1983 Apr; 31(4):479-87. PubMed ID: 6298307
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
6. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
7. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
8. Alpha-amidated peptides derived from pro-opiomelanocortin in human pituitary tumours.
Fenger M; Johnsen AH
J Endocrinol; 1988 Aug; 118(2):329-38. PubMed ID: 2844950
[TBL] [Abstract][Full Text] [Related]
9. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ACTH and ACTH precursor peptides secreted by human pituitary and lung tumour cells in vitro.
Crosby SR; Stewart MF; Farrell WE; Gibson S; White A
J Endocrinol; 1990 Apr; 125(1):147-52. PubMed ID: 2159969
[TBL] [Abstract][Full Text] [Related]
11. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
Reuss WA; Saeger W; Lüdecke DK
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
[TBL] [Abstract][Full Text] [Related]
12. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
13. Difference of lectin binding sites of secretory granules between normal pituitary and adenoma cells.
Hori T; Nishiyama F; Anno Y; Adachi S; Numata H; Hokama Y; Muraoka K; Hirano H
Acta Neuropathol; 1985; 66(3):177-83. PubMed ID: 2990144
[TBL] [Abstract][Full Text] [Related]
14. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
17. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor.
Miller WL; Johnson LK
J Clin Endocrinol Metab; 1982 Sep; 55(3):441-6. PubMed ID: 6284780
[TBL] [Abstract][Full Text] [Related]
19. "Joining peptide" of pro-opiomelanocortin. II. Interspecies heterogeneity of the joining peptide fragment.
Jahnke GD; Soldato CM; Erisman MD; DiAugustine RP; Lazarus LH
Peptides; 1983; 4(4):483-92. PubMed ID: 6647118
[TBL] [Abstract][Full Text] [Related]
20. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
